Feng-ze Wang
Taian, 271000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
6-Methoxydihydrosanguinarine Suppresses the Proliferation of Non-small Cell Lung Cancer Cells through Elevation of ROS and Activation of IRE1/JNK Signaling.
Journal: Cell biochemistry and biophysics
Published: July 22, 2025
CUDC-907 exerts an inhibitory effect on non-small cell lung cancer associated with induction of mitotic catastrophe and downregulation of YAP/TAZ signaling.
Journal: Chemico-biological interactions
Published: June 22, 2025
Scutebarbatine B Exerts Anti-Breast Cancer Activity by Inducing Cell Cycle Arrest and Apoptosis Through Multiple Pathways.
Journal: Phytotherapy research : PTR
Published: January 20, 2025
Daurisoline inhibits proliferation, induces apoptosis, and enhances TRAIL sensitivity of breast cancer cells by upregulating DR5.
Journal: Cell biology international
Published: November 25, 2023
6-Methoxydihydrosanguinarine exhibits cytotoxicity and sensitizes TRAIL-induced apoptosis of hepatocellular carcinoma cells through ROS-mediated upregulation of DR5.
Journal: Medical oncology (Northwood, London, England)
Published: May 09, 2023
Scutebarbatine A induces ROS-mediated DNA damage and apoptosis in breast cancer cells by modulating MAPK and EGFR/Akt signaling pathway.
Journal: Chemico-biological interactions
Published: November 30, 2022
Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells.
Journal: Chemico-biological interactions
Published: April 13, 2022
Corrigendum to "CCT128930 induces G1-phase arrest and apoptosis and synergistically enhances the anticancer efficiency of VS5584 in human osteosarcoma cells" [Biomed. Pharmacother. 130 (2020) 110544].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 01, 2020
CCT128930 induces G1-phase arrest and apoptosis and synergistically enhances the anticancer efficiency of VS5584 in human osteosarcoma cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 12, 2020
VS-5584 Inhibits Human Osteosarcoma Cells Growth by Induction of G1- phase Arrest through Regulating PI3K/mTOR and MAPK Pathways.
Journal: Current cancer drug targets
Published: December 05, 2019
CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cells.
Journal: Journal of cell communication and signaling
Published: November 01, 2019
Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 26, 2018
Last Updated: 09/26/2026